ConductScience.org, home

Paper39199587

Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update.

Bermúdez M and 5 others. Cancers (Basel), 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update. Papers, record 39199587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39199587

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.36, provisional
iCite
Revised in PubMed
2024-09-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bermúdez MMercedeshttps://orcid.org/0000-0002-6145-1134
2Martínez-Barajas MGMarcela Guadalupe
3Bueno-Urquiza LJLesly Jazmín
4López-Gutiérrez JAJorge Armando
5Villegas-Mercado CECarlos Estebanhttps://orcid.org/0000-0001-5729-4677
6López-Camarillo CCésarhttps://orcid.org/0000-0002-9417-2609

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
A1-S-13656Consejo Nacional de Humanidades Ciencia y Tecnologia, Mexico.PubMed

Source PubMed

Download CSV of grants

References125

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123768087MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.BMC Cancer2013https://conductscience.org/library/papers/23768087PubMed
226722467miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26722467PubMed
336931265Deciphering breast cancer: from biology to the clinic.Cell2023https://conductscience.org/library/papers/36931265PubMed
430710426An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.J Cell Mol Med2019https://conductscience.org/library/papers/30710426PubMed
524095958Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.Free Radic Biol Med2013https://conductscience.org/library/papers/24095958PubMed
630483765AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review).Int J Mol Med2019https://conductscience.org/library/papers/30483765PubMed
726464665MicroRNA-204 inhibits cell proliferation in T-cell acute lymphoblastic leukemia by down-regulating SOX4.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26464665PubMed
833655864Therapeutic Potential of microRNA Against Th2-associated Immune Disorders.Curr Top Med Chem2021https://conductscience.org/library/papers/33655864PubMed
928675122MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer.Tumour Biol2017https://conductscience.org/library/papers/28675122PubMed
1026209885Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer.Cytokine Growth Factor Rev2015https://conductscience.org/library/papers/26209885PubMed
1124321270A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.Mol Cancer2013https://conductscience.org/library/papers/24321270PubMed
1233406434Cancer Stemness Meets Immunity: From Mechanism to Therapy.Cell Rep2021https://conductscience.org/library/papers/33406434PubMed
1330737233Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.Cancer Res2019https://conductscience.org/library/papers/30737233PubMed
1419701242Biological determinants of endocrine resistance in breast cancer.Nat Rev Cancer2009https://conductscience.org/library/papers/19701242PubMed
1537620316Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia.Nat Commun2023https://conductscience.org/library/papers/37620316PubMed
1633345445Cancer-secreted miRNAs regulate amino-acid-induced mTORC1 signaling and fibroblast protein synthesis.EMBO Rep2021https://conductscience.org/library/papers/33345445PubMed
1732731349miRNAs in Health and Disease: A Focus on the Breast Cancer Metastatic Cascade towards the Brain.Cells2020https://conductscience.org/library/papers/32731349PubMed
1819470727FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.Clin Cancer Res2009https://conductscience.org/library/papers/19470727PubMed
1933785398Micro-RNA: The darkhorse of cancer.Cell Signal2021https://conductscience.org/library/papers/33785398PubMed
2036800999Spatial profiling technologies illuminate the tumor microenvironment.Cancer Cell2023https://conductscience.org/library/papers/36800999PubMed

See all 125 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42646605The Role of Autophagy in Cancer Evolution and Prognosis, Highlighting Its Role in PCa and Its Interaction with Apoptosis and Epigenetic Regulation by miRNAs.Med Sci (Basel)2026https://conductscience.org/library/papers/42646605PubMed
42410237OMIDIENT: Multiomics Integration for Cancer by Dirichlet Auto-Encoder Networks.Commun Biol2026https://conductscience.org/library/papers/42410237PubMed
42305518COL10A1 overexpression potentially contributes to poor outcomes in breast cancer via autophagy and vasculogenic mimicry.Transl Cancer Res2026https://conductscience.org/library/papers/42305518PubMed
41859360Targeting lncRNA DSCAM-AS1 for disease diagnosis and therapy.Noncoding RNA Res2026https://conductscience.org/library/papers/41859360PubMed
41614405Advances in the study of the breast carcinoma exosomal microRNAs: From basic mechanisms to clinical applications (Review).Int J Oncol2026https://conductscience.org/library/papers/41614405PubMed
41571856Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer.NPJ Precis Oncol2026https://conductscience.org/library/papers/41571856PubMed
41479038Mapping Non-Coding Epimutations in Breast Cancer: Advancing Epigenetics Towards Precision Medicine.Subcell Biochem2026https://conductscience.org/library/papers/41479038PubMed
41188982Ursolic acid suppresses gastric cancer by targeting the miR-27a-3p/Wnt/β-catenin signaling axis.Eur J Med Res2025https://conductscience.org/library/papers/41188982PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39199587

GET https://conductscience.org/api/papers/v1/39199587/references?page=2